Marinus Pharmaceuticals, INC.: directors' dealings · United States · SEC (Form 4)

Explore the full directors' dealings record of Marinus Pharmaceuticals, INC., a listed equity based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Technology sector, Marinus Pharmaceuticals, INC. has recorded 4 reports. Market capitalisation: €777.5bn. The latest transaction was reported on 26 May 2022 (Attribution). Among the most active insiders: Hulihan Joseph. Every trade is accessible without an account.